Limitations of high throughput methods for miRNA expression profiles in non-functioning pituitary adenomas
- 171 Downloads
Microarray, RT-qPCR based arrays and next-generation-sequencing (NGS) are available high-throughput methods for miRNA profiling (miRNome). Analytical and biological performance of these methods were tested in identification of biologically relevant miRNAs in non-functioning pituitary adenomas (NFPA). miRNome of 4 normal pituitary (NP) and 8 NFPA samples was determined by these platforms and expression of 21 individual miRNAs was measured on 30 (20 NFPA and 10 NP) independent samples. Complex bioinformatics was used. 132 and 137 miRNAs were detected by all three platforms in NP and NFPA, respectively, of which 25 were differentially expressed (fold change > 2). The strongest correlation was observed between microarray and TaqMan-array, while the data obtained by NGS were the most discordant despite of various bioinformatics settings. As a technical validation we measured the expression of 21 selected miRNAs by individual RT-qPCR and we were able to validate 35.1%, 76.2% and 71.4% of the miRNAs revealed by SOLiD, TLDA and microarray result, respectively. We performed biological validation using an extended number of samples (20 NFPAs and 8 NPs). Technical and biological validation showed high correlation (p < 0.001; R = 0.96). Pathway and network analysis revealed several common pathways but no pathway showed the same activation score. Using the 25 platform-independent miRNAs developmental pathways were the top functional categories relevant for NFPA genesis. The difference among high-throughput platforms is of great importance and selection of screening method can influence experimental results. Validation by another platform is essential in order to avoid or to minimalize the platform specific errors.
KeywordsmiRNA miRNA profiling Non-functioning pituitary adenoma
This work has been funded by National Research, Development and Innovation Office – NKFIH PD116093 to Henriett Butz. Attila Patocs is a recipient of “Lendulet” grant from Hungarian Academy of Sciences.
Compliance with Ethical Standards
Conflicts of Interest
The authors declare no potential conflicts of interest.
- 4.Zhang Z, Florez S, Gutierrez-Hartmann A et al (2010) MicroRNAs regulate pituitary development, and microRNA 26b specifically targets lymphoid enhancer factor 1 (Lef-1), which modulates pituitary transcription factor 1 (Pit-1) expression. J Biol Chem 285:34718–34728. https://doi.org/10.1074/jbc.M110.126441 CrossRefGoogle Scholar
- 16.Butz H, Németh K, Czenke D et al (2016) Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas. Pathol Oncol Res POR. https://doi.org/10.1007/s12253-016-0163-5
- 17.Thompson IR, Chand AN, King PJ et al (2012) Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide. Endocr Relat Cancer 19:497–508. https://doi.org/10.1530/ERC-12-0129 CrossRefGoogle Scholar
- 19.Harmati M, Tarnai Z, Decsi G et al (2016) Stressors alter intercellular communication and exosome profile of nasopharyngeal carcinoma cells. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. https://doi.org/10.1111/jop.12486